Biotech and the Race for a Vaccine

by Carmen Tang, AGF Management Ltd.

For Print Only Logo

Insights and Market Perspectives

Author: Carmen Tang

March 13, 2020

Carmen Tang, AGF equity analyst, discusses the efforts now ongoing across the biotechnology sector to help combat the COVID-19 virus.

About AGF Management Limited

Founded in 1957, AGF Management Limited (AGF) is an independent and globally diverse asset management firm. AGF brings a disciplined approach to delivering excellence in investment management through its fundamental, quantitative, alternative and high-net-worth businesses focused on providing an exceptional client experience. AGF’s suite of investment solutions extends globally to a wide range of clients, from financial advisors and individual investors to institutional investors including pension plans, corporate plans, sovereign wealth funds and endowments and foundations.

For further information, please visit AGF.com.

© 2020 AGF Management Limited. All rights reserved.

This post was first published at the AGF Perspectives Blog.

Total
0
Shares
Previous Article

Panic is Not an Investment Strategy

Next Article

What could short-term volatility mean for long-term investors?

Related Posts
Read More

The 4th Turning of Markets: Darius Dale on Inflation, Debt & Investing in 2025

What if everything you thought you knew about the Fed, fiscal policy, and recession playbooks is already obsolete? In this episode, Darius Dale reveals why the U.S. economy has entered “Paradigm C” — a regime of fiscal dominance, deregulation, and coordinated support — and what it means for portfolios, the Fed, and your financial future.
Subscribe to AdvisorAnalyst.com notifications
Watch. Listen. Read. Raise your average.